These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20396921)

  • 21. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
    Li C; Wang XR; Ji HJ; Zhang XY; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai B; Li XF; Song LJ; Wang Y; Wang XY; Tang YD; Su Y; Mu R; Li ZG
    Clin Rheumatol; 2017 May; 36(5):1023-1029. PubMed ID: 28342151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of cardiovascular disease in rheumatoid arthritis.
    Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
    Autoimmun Rev; 2015 Oct; 14(10):952-69. PubMed ID: 26117596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.
    Panoulas VF; Douglas KM; Stavropoulos-Kalinoglou A; Metsios GS; Nightingale P; Kita MD; Elisaf MS; Kitas GD
    Rheumatology (Oxford); 2008 Jan; 47(1):72-5. PubMed ID: 18077493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
    Agca R; Hopman LHGA; Laan KJC; van Halm VP; Peters MJL; Smulders YM; Dekker JM; Nijpels G; Stehouwer CDA; Voskuyl AE; Boers M; Lems WF; Nurmohamed MT
    J Rheumatol; 2020 Mar; 47(3):316-324. PubMed ID: 31092721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
    Fragoulis GE; Panayotidis I; Nikiphorou E
    Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.
    Stavropoulos-Kalinoglou A; Metsios GS; Panoulas VF; Douglas KM; Nevill AM; Jamurtas AZ; Kita M; Koutedakis Y; Kitas GD
    Ann Rheum Dis; 2009 Feb; 68(2):242-5. PubMed ID: 18677010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals.
    Mori S; Yoshitama T; Hirakata N; Ueki Y
    Clin Rheumatol; 2017 Dec; 36(12):2673-2682. PubMed ID: 28884373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microalbuminuria in diabetic and hypertensive patients and the general population--consequences of various diagnostic criteria--the Nord-Trøndelag Health Study (HUNT).
    Hallan H; Romundstad S; Kvenild K; Holmen J
    Scand J Urol Nephrol; 2003; 37(2):151-8. PubMed ID: 12745725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
    Ruscitti P; Margiotta DPE; Macaluso F; Iacono D; D'Onofrio F; Emmi G; Atzeni F; Prete M; Perosa F; Sarzi-Puttini P; Emmi L; Cantatore FP; Triolo G; Afeltra A; Giacomelli R; Valentini G
    Medicine (Baltimore); 2017 Oct; 96(42):e8180. PubMed ID: 29049200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study.
    Cao JJ; Barzilay JI; Peterson D; Manolio TA; Psaty BM; Kuller L; Wexler J; Bleyer AJ; Cushman M
    Atherosclerosis; 2006 Aug; 187(2):372-7. PubMed ID: 16242696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.
    Mackey RH; Kuller LH; Deane KD; Walitt BT; Chang YF; Holers VM; Robinson WH; Tracy RP; Hlatky MA; Eaton CB; Liu S; Freiberg MS; Talabi MB; Schelbert EB; Moreland LW
    Arthritis Rheumatol; 2015 Sep; 67(9):2311-22. PubMed ID: 25988241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
    van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
    Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.
    Oliveras A; Armario P; Sierra C; Arroyo JA; Hernández-del-Rey R; Vazquez S; Larrousse M; Sans L; Roca-Cusachs A; de la Sierra A
    Am J Hypertens; 2013 Sep; 26(9):1148-54. PubMed ID: 23747954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
    Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.
    Ruscitti P; Ursini F; Cipriani P; Ciccia F; Liakouli V; Carubbi F; Guggino G; Berardicurti O; Grembiale R; Triolo G; De Sarro G; Giacomelli R
    Medicine (Baltimore); 2017 Aug; 96(34):e7896. PubMed ID: 28834907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of metabolic syndrome and albuminuria with cardiovascular risk in occupational drivers.
    Chen SC; Chang JM; Lin MY; Hou ML; Tsai JC; Hwang SJ; Chen HC
    Int J Mol Sci; 2013 Nov; 14(11):21997-2010. PubMed ID: 24201129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study.
    Yuyun MF; Khaw KT; Luben R; Welch A; Bingham S; Day NE; Wareham NJ;
    Int J Epidemiol; 2004 Feb; 33(1):189-98. PubMed ID: 15075168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors.
    Burgert TS; Dziura J; Yeckel C; Taksali SE; Weiss R; Tamborlane W; Caprio S
    Int J Obes (Lond); 2006 Feb; 30(2):273-80. PubMed ID: 16231019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of serum uric acid with cardiovascular disease in rheumatoid arthritis.
    Panoulas VF; Milionis HJ; Douglas KM; Nightingale P; Kita MD; Klocke R; Elisaf MS; Kitas GD
    Rheumatology (Oxford); 2007 Sep; 46(9):1466-70. PubMed ID: 17644822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target organ damage in patients with rheumatoid arthritis: the role of blood pressure and heart rate.
    Panoulas VF; Toms TE; Metsios GS; Stavropoulos-Kalinoglou A; Kosovitsas A; Milionis HJ; Douglas KM; John H; Kitas GD
    Atherosclerosis; 2010 Mar; 209(1):255-60. PubMed ID: 19781703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.